ArticleScientific reports2026
Isorhamnetin inhibits mechanical stress-induced chondrocyte apoptosis through activation of the ROS/SRC/FOXO1 signaling pathway.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Intervertebral disc degeneration (IDD), a chronic degenerative disease, is characterized by pain without a satisfactory therapeutic strategy. Excessive mechanical pressure contributes to the pathological development of IDD by inducing chondrocyte apoptosis in the cartilage endplate. Isorhamnetin (ISO) has been shown to have chondroprotective effects by promoting chondrocyte proliferation and inhibiting chondrocyte apoptosis. In this study, we found that mechanical loading could inactivate the SRC/FOXO1 signaling pathway and increase chondrocyte apoptosis, leading to disc degeneration in rats. ISO neutralized mechanical loading-induced chondrocyte apoptosis and attenuated the progression of disc degeneration. However, activation of ROS/SRC/FOXO1 signaling by EPQpYEEIPIYL (EPQ) and H2O2 attenuated the biological effects of ISO on mechanical loading-treated chondrocytes. Therefore, ISO may protect against mechanical loading-induced injury and inhibit chondrocyte apoptosis through the activation of the ROS/SRC/FOXO1 signaling pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.